[Mitomycin C in glaucoma filtering surgery]

M Vása1, P Rozsíval

  • 1Ocní klinika FN, Hradec Králové.

Insights

Mitomycin C application during glaucoma surgery showed an 84.7% intraocular pressure compensation rate. However, higher concentrations (0.4 mg/ml) increased complication risks, including vision loss.

Area of Science:

  • Ophthalmology
  • Surgical Innovation

Context:

  • Glaucoma filtering surgery aims to reduce intraocular pressure (IOP).
  • Mitomycin C is an antimetabolite used to enhance surgical outcomes.
  • Evaluating the efficacy and safety of mitomycin C in glaucoma surgery is crucial.

Purpose:

  • To assess the effectiveness of topical mitomycin C (0.2-0.4 mg/ml) in glaucoma filtering surgery.
  • To analyze the complication rates and visual acuity changes associated with mitomycin C use.
  • To determine the intraocular pressure (IOP) control achieved with mitomycin C application.

Summary:

  • This study evaluated 67 patients (75 eyes) undergoing glaucoma surgery with mitomycin C, with a mean follow-up of 19.5 months.
  • Intraocular pressure (IOP) compensation was achieved in 84.7% of cases post-mitomycin C application.
  • Serious complications, such as endophthalmitis and retinal detachment, were noted, particularly at the higher concentration of 0.4 mg/ml.

Impact:

  • Mitomycin C demonstrates significant potential for IOP control in glaucoma surgery.
  • Careful consideration of mitomycin C concentration is necessary to minimize serious adverse events.
  • Further research may optimize mitomycin C protocols for improved glaucoma treatment outcomes.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...